Owlstone Medical Ltd.

Biotech valuations and funding availability went into reverse in the second half of 2021, following a period of abundant financing. Meanwhile, big pharma companies face their own problems, with many b

“I’m optimistic when it comes to both the integration and the impact of transformative technologies across the life sciences industry,” said Jessica Federer , Bayer ’s former chief digital officer a

Owlstone Medical , the UK-based developer of “breath biomarkers” for various medical diagnostics purposes, has won a contract from the US Department of Defense that will put a lightweight, portable ve

Owlstone Medical , a subsidiary of Owlstone, raised $58m in an oversubscribed funding round to continue development of its breath biopsy technology. The series D round, announced 7 September, raised $